RankAlpha logo
Back to Rankings

ORIC

OricF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
ORIC vs peer average
15/100
ORIC vs. peer average (F vs. C)
Grade spread
A 2 · B 2 · C 1 · D 2 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

PHAR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $922.86M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPHARPharming Group
ORIC
Oric
PHAR
Pharming Group
Grade
F
A
Momentum
6
65
Value
41
62
Sentiment
-
63
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs PHAR

ORIC / PHAR
Grade Position
Below peers
ORIC vs. peer average (F vs. C)
15/100
Momentum
6
PHAR
Value
41
PHAR
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ORIC
1
PHAR
Pharming Group NV ADR
A
100/100
-4
2
SPRY
ARS Pharmaceuticals Inc Common
B
80/100
-3
3
LXRX
Lexicon Pharmaceuticals Inc Common
D
40/100
-1
4
JBIO
Jade Biosciences Inc Common
A
100/100
-4
5
ANNX
Annexon Inc Common
C
60/100
-2
PHAR is the first peer returned for this comparison set.